Matt Zuga, CFO & Chief Business Officer at Acumen Pharmaceuticals, Inc. (ABOS), sold 33,266 shares at $1.60 ($57K) on 2025-01-21, disclosed to the SEC on 2025-01-23.
Scheduled sale ($57k) by CFO & Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.60 | 4,364 | $7K | 12.3% |
| 2 | $1.72 | 28,902 | $50K | 87.7% |
| Total | $1.70 avg | 33,266 | $57K | 100% |
| Filing → |
| ABOS | SELL | 2026-01-07 | $59K | — | Filing → |
| ABOS | SELL | 2025-01-07 | $24K | — | Filing → |
| ABOS | SELL | 2024-01-19 | $16K | — | Filing → |